Journal article
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
Gregory M LaMonte, Frances Rocamora, Danushka S Marapana, Nina F Gnadig, Sabine Ottilie, Madeline R Luth, Tilla S Worgall, Gregory M Goldgof, Roxanne Mohunlal, TR Santha Kumar, Jennifer K Thompson, Edgar Vigil, Jennifer Yang, Dylan Hutson, Trevor Johnson, Jianbo Huang, Roy M Williams, Bing Yu Zou, Andrea L Cheung, Prianka Kumar Show all
Nature Communications | NATURE PUBLISHING GROUP | Published : 2020
Grants
Awarded by Bill and Melinda Gates Foundation
Awarded by National Research Foundation of South Africa
Awarded by Ruth L. Kirschstein Institutional National Research Award from the National Institute for General Medical Sciences
Awarded by Bill & Melinda Gates Foundation
Awarded by NIH
Funding Acknowledgements
We would like to thank the members of the Winzeler lab for technical support, reagents and critical reading of the manuscript. G.L. is supported by an AP Giannini post-doctoral fellowship. S.O. and G.M.G. were funded by the Bill and Melinda Gates Foundation (OPP1054480, and OPP1171497). T.J.E. and R.M. were supported by the National Research Foundation of South Africa (Grant No. 91516). R.M. also acknowledges the University of Cape Town for a travel grant. M.R.L. was supported in part by a Ruth L. Kirschstein Institutional National Research Award from the National Institute for General Medical Sciences (T32 GM008666). M.C.L gratefully acknowledges funding from Wellcome and the Bill and Melinda Gates Foundation. D.A.F. gratefully acknowledges funding from the Medicines for Malaria Venture and the Bill & Melinda Gates Foundation. E.A.W. is supported by grants from the NIH (5R01AI090141 and R01AI103058) and by grants from the Bill & Melinda Gates Foundation (OPP1086217and OPP1141300) as well as by Medicines for Malaria Venture (MMV).